Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence and dose-volume relationship of radiation pneumonitis after concurrent chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer.
Saito S, Abe T, Kobayashi N, Aoshika T, Ryuno Y, Igari M, Hirai R, Kumazaki Y, Miura Y, Kaira K, Kagamu H, Noda SE, Kato S. Saito S, et al. Among authors: aoshika t. Clin Transl Radiat Oncol. 2020 May 30;23:85-88. doi: 10.1016/j.ctro.2020.05.006. eCollection 2020 Jul. Clin Transl Radiat Oncol. 2020. PMID: 32529055 Free PMC article.
Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer in comparison with chemoradiotherapy alone.
Abe T, Saito S, Iino M, Aoshika T, Ryuno Y, Ohta T, Igari M, Hirai R, Kumazaki Y, Miura Y, Kaira K, Kagamu H, Noda SE, Kato S. Abe T, et al. Among authors: aoshika t. Thorac Cancer. 2021 Jan;12(2):245-250. doi: 10.1111/1759-7714.13764. Epub 2020 Dec 1. Thorac Cancer. 2021. PMID: 33289347 Free PMC article.
Simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer treated with intensity modulated radiotherapy.
Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, Ohta T, Igari M, Hirai R, Kumazaki Y, Miura Y, Kaira K, Kagamu H, Noda S, Kato S. Abe T, et al. Among authors: aoshika t. Thorac Cancer. 2022 Oct;13(20):2890-2896. doi: 10.1111/1759-7714.14634. Epub 2022 Aug 31. Thorac Cancer. 2022. PMID: 36054298 Free PMC article.
An Asian multi-national multi-institutional retrospective study comparing intracavitary versus the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical carcinoma.
Murakami N, Ando K, Murata M, Murata K, Ohno T, Aoshika T, Kato S, Okonogi N, Saito AI, Kim JY, Yoshioka Y, Sekii S, Tsujino K, Lowanichkiattikul C, Pattaranutaporn P, Kaneyasu Y, Nakagawa T, Watanabe M, Uno T, Umezawa R, Jingu K, Kanemoto A, Wakatsuki M, Shirai K, Igaki H, Itami J. Murakami N, et al. Among authors: aoshika t. J Radiat Res. 2022 May 18;63(3):412-427. doi: 10.1093/jrr/rrac014. J Radiat Res. 2022. PMID: 35446962 Free PMC article.
Why not de-intensification for uterine cervical cancer?
Murakami N, Ando K, Murata M, Murata K, Ohno T, Aoshika T, Kato S, Okonogi N, Saito AI, Kim JY, Kumai Y, Yoshioka Y, Sekii S, Tsujino K, Lowanichkiattikul C, Pattaranutaporn P, Kaneyasu Y, Nakagawa T, Watanabe M, Uno T, Umezawa R, Jingu K, Kanemoto A, Wakatsuki M, Shirai K, Igaki H, Itami J. Murakami N, et al. Among authors: aoshika t. Gynecol Oncol. 2021 Oct;163(1):105-109. doi: 10.1016/j.ygyno.2021.07.021. Epub 2021 Jul 19. Gynecol Oncol. 2021. PMID: 34294413
Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial.
Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, Machitori Y, Aoshika T, Kato S, Hirowatari H, Kaneyasu Y, Nakagawa T, Ikushima H, Ando K, Murata M, Yoshida K, Yoshioka H, Murata K, Ohno T, Okonogi N, Saito A, Ichikawa M, Okuda T, Tsuchida K, Sakurai H, Yoshimura R, Yoshioka Y, Yorozu A, Okamoto H, Inaba K, Kato T, Igaki H, Itami J. Murakami N, et al. Among authors: aoshika t. Jpn J Clin Oncol. 2022 Aug 5;52(8):859-868. doi: 10.1093/jjco/hyac072. Jpn J Clin Oncol. 2022. PMID: 35470390 Clinical Trial.
An Asian multi-national, multi-institutional, retrospective study on image-guided brachytherapy in cervical adenocarcinoma and adenosquamous carcinoma.
Okonogi N, Murakami N, Ando K, Murata M, Murata K, Aoshika T, Kato S, Saito AI, Kim JY, Yoshioka Y, Sekii S, Tsujino K, Lowanichkiattikul C, Pattaranutaporn P, Kaneyasu Y, Nakagawa T, Watanabe M, Uno T, Umezawa R, Jingu K, Kanemoto A, Wakatsuki M, Shirai K, Igaki H, Ohno T, Itami J. Okonogi N, et al. Among authors: aoshika t. J Contemp Brachytherapy. 2022 Aug;14(4):311-320. doi: 10.5114/jcb.2022.119451. Epub 2022 Aug 31. J Contemp Brachytherapy. 2022. PMID: 36199951 Free PMC article.
Salvage image-guided freehand interstitial brachytherapy for pelvic sidewall recurrence after hysterectomy for uterine malignancies.
Miyata Y, Murakami N, Okuma K, Shimizu Y, Takahashi A, Kashihara T, Kaneda T, Takahashi K, Inaba K, Sakuramachi M, Kojima K, Aoshika T, Morishima K, Nakayama Y, Itami J, Kato T, Ogo E, Igaki H. Miyata Y, et al. Among authors: aoshika t. Brachytherapy. 2022 Sep-Oct;21(5):647-657. doi: 10.1016/j.brachy.2022.04.009. Epub 2022 Jun 21. Brachytherapy. 2022. PMID: 35750619
Comparison of the Efficacy and Toxicity of Concurrent Chemoradiotherapy and Durvalumab and Concurrent Chemoradiotherapy Alone for Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Metastasis.
Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, Ohta T, Igari M, Hirai R, Kumazaki YU, Miura YU, Kaira K, Kagamu H, Noda SE, Kato S. Abe T, et al. Among authors: aoshika t. Anticancer Res. 2023 Feb;43(2):675-682. doi: 10.21873/anticanres.16205. Anticancer Res. 2023. PMID: 36697072
Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer.
Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, Machitori Y, Aoshika T, Kato S, Hirowatari H, Kaneyasu Y, Nakagawa T, Ikushima H, Ando K, Murata M, Yoshida K, Yoshioka H, Murata K, Ohno T, Okonogi N, Saito AI, Ichikawa M, Okuda T, Tsuchida K, Sakurai H, Yoshimura R, Yoshioka Y, Yorozu A, Kunitake N, Okamoto H, Inaba K, Kato T, Igaki H, Itami J. Murakami N, et al. Among authors: aoshika t. J Gynecol Oncol. 2023 May;34(3):e24. doi: 10.3802/jgo.2023.34.e24. Epub 2022 Dec 21. J Gynecol Oncol. 2023. PMID: 36603849 Free PMC article. Clinical Trial.